Alopecia areata

Kirsten Rønholt, Stine Simonsen, Farnam Barati Sedeh, Lone Skov

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Abstract

Alopecia areata (AA) is an autoimmune disease where inflammation around the lowest part of the hair follicle results in non-scarring hair loss. This review investigates the course of the disease, its unpredictability and variation from a single patch of scalp hair loss to the loss of all hair on the body. The first drug with AA indication was approved in 2022, the JAK-inhibitor baricitinib. This paves the way for future research that may lead to the development of new effective pathogenesis-specific treatments.

Bidragets oversatte titelAlopecia areata
OriginalsprogDansk
ArtikelnummerV07230456
Antal sider10
TidsskriftUgeskrift for Laeger
Vol/bind185
Udgave nummer47
StatusUdgivet - 20 nov. 2023

Bibliografisk note

Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Emneord

  • Alopecia
  • Alopecia Areata/drug therapy
  • Autoimmune Diseases
  • Humans
  • Janus Kinase Inhibitors

Fingeraftryk

Udforsk hvilke forskningsemner 'Alopecia areata' indeholder.

Citationsformater